www.statnews.com Open in urlscan Pro
2606:4700::6812:1b65  Public Scan

Form analysis
2 forms found in the DOM

GET https://www.statnews.com/

<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
  <input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
  <button type="submit" class="header-btn header-btn-search">Search</button>
  <button class="header-btn header-btn-back">Cancel</button>
</form>

POST

<form id="coral-display-name-form" class="coral-display-name-form stat-form" method="post">
  <input type="text" id="enter-display-name-input" name="display" placeholder="Create a display name" value="">
  <p id="enter-display-name-error" style="display: none">There was an error saving your display name. Please check and try again.</p>
  <input type="submit" value="Continue">
</form>

Text Content

Skip to Main Content
 * 
 * 
 * 
 * Community

Try STAT+ TODAY

 * Contribute
 * Log In
 * Try STAT+ TODAY

My Account
 * My Account
 * Billing
 * Log In

Try STAT+ TODAY My Account
Search Cancel
 * TOPICS
   * Coronavirus
   * Health
   * Pharma
   * Biotech
   * Politics & Policy
   * Health Tech
   * In the Lab
   * Business
   * Artificial Intelligence
   * Vaccines
   * Health Disparities
   * Prescription Politics
 * OPINION
   * First Opinion
   * The Pharmalot View
   * Adam's Take
   * Matt's Take
   * Off the Charts
 * TEAM
   
   * Biotech & Pharma
     
     * Adam Feuerstein
     * Damian Garde
     * Matthew Herper
     * Meghana Keshavan
     * Kate Sheridan
     * Ed Silverman
     * Jonathan Wosen
   
   * Health Tech
     
     * Mario Aguilar
     * Katie Palmer
     * Mohana Ravindranath
     * Casey Ross
   
   * Business & Policy
     
     * Rachel Cohrs
     * Lev Facher
     * Nicholas Florko
     * Bob Herman
   
   * Health & Science
     
     * Eric Boodman
     * Helen Branswell
     * Angus Chen
     * Elizabeth Cooney
     * Isabella Cueto
     * Theresa Gaffney
     * Olivia Goldhill
     * Andrew Joseph
     * Megan Molteni
     * Usha Lee McFarling
     * Jennifer Adaeze Okwerekwu
     * Nicholas St. Fleur
   
   * Team
     
     * View All
 * EVENTS
   * STAT Events
   * 2022 STAT Breakthrough Science Summit
   * Industry Events Calendar
   * View all Summits
   * Webinars
 * PODCASTS
   * The Readout LOUD
   * First Opinion Podcast
 * NEWSLETTERS
 * RESOURCES
   * STAT Trials Pulse
   * Reports
   * E-books
 * VIDEO
 * 
 * STAT+
   
   * Exclusive analysis of biotech, pharma, and the life sciences
     
     Learn More
     * The Latest
     * My Account
   
   * Topics
     
     * Biotech
     * Pharma
     * Policy
     * Health Tech
     * Business
   
   * Columns
     
     * Adam's Take
     * Matt's Take
     * The Pharmalot View
   
   * Tools
     
     * CRISPR Trackr
     * Drug Pricing Policy Cheat Sheet
   
   * Events
     
     * STAT+ Conversations
     * All STAT Events
   
   * Team
     
     * Biotech and Pharma
     * Health Tech
     * Politics and Policy
     * Health and Science

Account

 * My Account
 * Billing
 * Subscribe
 * Log In
 * Help

More

 * Community
 * Contribute
 * Group Subscriptions

Follow Us

 * 
 * 
 * 
 * 
 * 

Trending:
Coronavirus
Pharmalot
First Opinion
Biotech

Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories

In-depth analysis of biotech, pharma, and the life sciences

 * AWARD-WINNING JOURNALISM
   
   from some of the nation's most trusted and well-connected reporters in the
   industry

 * WEEKLY LIVE VIDEO CHATS
   
   with STAT+ reporters and leading industry experts in our STAT+ Conversations
   series

 * EXCLUSIVE INDUSTRY EVENTS
   
   hosted by STAT+, plus early-bird access and discounts to industry events
   around the country

 * DAILY STAT+ NEWSLETTERS
   
   get delivered to your inbox to brief you on the most important industry news
   of the day

 * PREMIUM DATA TOOLS
   
   like our CRISPR Trackr and Drug Pricing Policy Tracker


EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES

Try STAT+ 30 days FREE Learn More

In-depth analysis of biotech, pharma, and the life sciences

 * AWARD-WINNING JOURNALISM
   
   from some of the nation's most trusted and well-connected reporters in the
   industry

 * WEEKLY LIVE VIDEO CHATS
   
   with STAT+ reporters and leading industry experts in our STAT+ Conversations
   series

 * EXCLUSIVE INDUSTRY EVENTS
   
   hosted by STAT+, plus early-bird access and discounts to industry events
   around the country

 * DAILY STAT+ NEWSLETTERS
   
   get delivered to your inbox to brief you on the most important industry news
   of the day

 * PREMIUM DATA TOOLS
   
   like our CRISPR Trackr and Drug Pricing Policy Tracker


EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES

Try STAT+ 30 days FREE Learn More
Health Tech


MICROSOFT CLOSES $16B ACQUISITION OF NUANCE, LAUNCHING A BOLD EXPERIMENT IN
HEALTH AI

 * 

By Casey Ross March 4, 2022

Reprints
 * + Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

JOSEP LAGO/AFP via Getty Images
 * 0 Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

AI’s next big health care experiment can now begin.

Microsoft closed on a $16 billion acquisition of Nuance Communications Friday,
launching a plan to leverage its speech recognition software and other AI
capabilities to seize what the tech giant sees as a $500 billion market
opportunity.

Unlock this article — and get additional analysis of the technologies disrupting
health care — by subscribing to STAT+. First 30 days free.

GET STARTED
Log In
 * 0 Comments
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 


ABOUT THE AUTHOR REPRINTS


CASEY ROSS

National Technology Correspondent

Casey covers the use of artificial intelligence in medicine and its underlying
questions of safety, fairness, and privacy. He is the co-author of the
newsletter STAT Health Tech.


casey.ross@statnews.com

@caseymross


TAGS

Health IT

medical technology

STAT+


Add a Comment


CREATE A DISPLAY NAME TO COMMENT

This name will appear with your comment

There was an error saving your display name. Please check and try again.




EXCLUSIVE BIOPHARMA, HEALTH POLICY, AND LIFE SCIENCE ANALYSIS. START YOUR 30-DAY
FREE TRIAL TODAY.

TRY STAT+


CATCH UP ON THE LATEST MUST-READ COVERAGE AND ANALYSIS

Read Now

advertisement



 * 
   Congress considers a longer phase-out of looser, Covid-era telehealth
   policies
 * 
   Congress moves toward giving FDA authority over synthetic nicotine products
   like Puff Bar
 * 
   Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate
   revives legislation to curb insulin costs

Learn more about STAT+

advertisement



Trending
Gaslighting of Black medical trainees makes residency something to…
Gaslighting of Black medical trainees makes residency something to ‘survive’

Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time

Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate…
Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate revives
legislation to curb insulin costs
Recommended
As providers are accused of interfering with access to…
As providers are accused of interfering with access to patient data, pressure
builds on government to…

Dozens of towns and counties object to ‘hush money’…
Dozens of towns and counties object to ‘hush money’ tied to Purdue opioid
settlement

Gilead’s Dan O’Day is pharma’s most charming executive —…
Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals
falling apart, charm…


RECOMMENDED STORIES

Matt's Take


GILEAD’S DAN O’DAY IS PHARMA’S MOST CHARMING EXECUTIVE — BUT WITH HIS DEALS
FALLING APART, CHARM MAY NOT BE ENOUGH

By Matthew Herper

Pharmalot


PHARMALITTLE: U.S. LAWMAKER PROPOSES BILL TO CURTAIL FDA’S ACCELERATED APPROVAL;
MODERNA TO ENFORCE COVID PATENTS IN WEALTHY COUNTRIES

By Ed Silverman

advertisement


Biotech


WITH ADUHELM IN LIMBO, BIOGEN STARTS LAYING OFF EMPLOYEES

By Adam Feuerstein and Damian Garde

Special Report


WHY FORMALLY ENDING THE PANDEMIC IS GOING TO BE A HUGE HEADACHE FOR THE ENTIRE
HEALTH CARE SYSTEM

By Rachel Cohrs

Biotech


UC BERKELEY LOSES CRISPR PATENT CASE, INVALIDATING PATENT RIGHTS IT GRANTED
GENE-EDITING COMPANIES DEVELOPING HUMAN THERAPIES

By Megan Molteni

Reporting from the frontiers of health and medicine

Trending:
 * Coronavirus
 * Pharmalot
 * First Opinion
 * Biotech
 * Pharma
 * Health

Back to top


COMPANY

 * About STAT
 * Awards
 * Contact Us
 * Careers & Internships
 * Contribute
 * Diversity & Inclusion
 * Licensing Stories
 * Our Team


ACCOUNT

 * About STAT+
 * FAQs
 * Log In
 * Subscribe


APP & OTHER PRODUCTS

 * STAT App
 * Newsletters
 * Podcasts
 * STAT Madness
 * STAT Reports
 * STAT Trials Pulse
 * STAT Wunderkinds


GROUP SUBSCRIPTIONS

 * Contact Us
 * Request A Quote


ADVERTISING

 * Advertise With Us
 * Download Media Kit


EVENTS

 * Industry Events Calendar
 * STAT Events
 * STAT Summits
 * Sponsor An Event

 * Privacy
 * Comment Policy
 * Terms
 * Do Not Sell my Data
 * ©2022 STAT

 * 
 * 
 * 
 * 
 * 




Please review our cookie policy

We use first- and third-party cookies to customize your experience and display
advertising. By continuing to use the site, you agree to our use of cookies. If
you want to know more or opt out in whole or in part, please see our Privacy
Notice and our Cookie FAQ.

Accept No thanks